NewsBenzingaB. Riley Securities维持对OptimizeRx的买入评级，将目标股价上调至11美元 B. Riley Securities维持对OptimizeRx的买入评级，将目标股价上调至11美元 Benzinga 2026.09.29 15:42 (GMT+0) Open on Benzinga Other news Earnings Preview: What to Expect From Mosaic’s Report Gartner’s Q3 2026 Earnings: What to Expect Global Payments’ Quarterly Earnings Preview: What You Need to Know Earnings Preview: What to Expect From Assurant Report What a New Nvidia-Backed AI Platform Means for Honeywell Stock What You Need to Know Ahead of Yum! Brands' Earnings Release
